Stilla Technologies adds 20 new oncology liquid biopsies kits to its reagents portfolio from partner ApexBio

Stilla Technologies today announced the availability of 20 new digital PCR assays, optimized for its Crystal Digital PCR platform, the naica® system, to be utilized for the detection of circulating tumor

Related Keywords

France ,Athens ,Attikír ,Greece ,Paris ,France General ,United States ,Boston ,Massachusetts ,China ,American ,Remi Dangla ,Christopher Hynes ,Atila Biosystems ,Promega Corporation ,American Association Of Cancer Research ,University Of Athens ,Stilla Technologies ,Crystal Digital ,Chief Technology Officer ,Annual Meeting ,American Association ,Cancer Research ,Bastilla ,Technologies ,Odds ,Ncology ,Liquid ,Biopsies ,Its ,Eagents ,Portfolio ,Rom ,Partner ,Pexbio ,